- GYRE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-Q/A Filing
Gyre Therapeutics (GYRE) 10-Q/A2014 Q1 Quarterly report (amended)
Filed: 9 Jun 14, 12:00am
Exhibit 31.1
CERTIFICATION PURSUANT TO RULE 13A-14(A) AND 15D-14(A) OF THE SECURITIES
EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Stephen A. Hill, certify that:
1. I have reviewed this Amendment No. 1 to the Quarterly Report on Form 10-Q/A of Targacept, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Date: June 9, 2014 |
/s/ Stephen A. Hill |
Stephen A. Hill |
President and Chief Executive Officer |
(Principal Executive Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.